New York, USA - October 18, 2024 - Stationing at Booth #12, Creative Biolabs will highlight its capabilities in antibody discovery, demonstrating its role as a go-to partner in the ever-evolving drug discovery field.
"The 21st BioPharma Drug Discovery Nexus Conference stands as a premier gathering for industry experts and service providers to network and explore new business opportunities." A delegate intensively preparing for the event says.
With a focus on staying ahead in the competitive landscape, the event will see Creative Biolabs leveraging its booth to engage attendees in meaningful conversations about how its innovative services can accelerate the journey from target identification to market-potential therapies.
Unmatched Expertise in Monoclonal Antibody Discovery
Monoclonal antibodies stand as a cornerstone in modern therapeutics, offering highly specific targeting for a variety of diseases, from oncology to autoimmune disorders. At the heart of Creative Biolabs' participation will be its monoclonal antibody discovery services, which leverage innovative platforms such as immune antibody libraries to produce monoclonal antibodies from various host species:
* Monoclonal Human Antibody
* Monoclonal NHP Antibody
* Monoclonal Mouse Antibody
* Monoclonal Rat Antibody
* Monoclonal Rabbit Antibody
* Chicken IgY Antibody
* Monoclonal Camel Antibody
Attendees will be able to hear more about these strategies straight from the experts, as well as how Creative Biolabs may help to accommodate to develop antibodies from other model organisms like zebrafish.
Revolutionizing Epitope Mapping & Discovery
Epitope mapping critically helps to understand the interactions between antibodies and antigens. Creative Biolabs provides advanced epitope mapping and discovery services that streamline the antibody-based therapeutic development process-employing the CreMap™ platform to conduct peptide scanning, mutagenesis, and computational modeling, thus delivering detailed insights into antibody-antigen interactions like high antigenicity epitopes, peptide epitope sequences, and binding sites, which are pivotal for optimizing antibody efficacy and minimizing potential off-target effects.
At the conference, Creative Biolabs will also present related cases about epitope mapping and answer visitors' questions regarding the technology.
Innovating with Immune Repertoire Analysis
Another focal point for Creative Biolabs at the conference will be their immune repertoire analysis programs that open access to understanding an individual's immune response against foreign substances in a helicopter view, which is increasingly becoming an essential element in personalized medicine discovery.
* BCR Repertoire
* TCR Repertoire
* Peptide Repertoire
* Antibody Repertoire
* Bioactive Peptide Discovery
* Quantitative Immune Repertoire for Small Lymphocytes
"Next-generation sequencing and proprietary bioinformatics tools are utilized," said the delegate, "with which we conduct the profiling of the B cell and T cell repertoires, allowing for a deeper understanding of immune responses."
The 21st BioPharma Drug Discovery Nexus Conference will be a vibrant space for Creative Biolabs to engage with key industry players, explore collaborative opportunities, and showcase their world-class capabilities.
"Make sure to stop by Booth #12 and see how we're prepared to partner with you and advance your drug discovery endeavors. See you at Nexus!" The delegate says.
For more information on their services and event arrangements, visit https://www.creative-biolabs.com and explore how they're revolutionizing therapeutic antibody development.
About
Creative Biolabs continues to lead the charge in antibody discovery, ensuring the future of therapeutics is as dynamic as the needs of patients. Their team will be participating in industry exhibitions throughout the rest of the year, including the Annual World ADC San Diego and Antibody Engineering & Therapeutics in December.
Media Contact
Company Name: Creative Biolabs
Contact Person: Candy Swift
Email: Send Email
Phone: 1-631-830-6441
Country: United States
Website: https://www.creative-biolabs.com
